166 related articles for article (PubMed ID: 19121441)
1. Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation.
Lewis WR; Fonarow GC; LaBresh KA; Cannon CP; Pan W; Super DM; Sorof SA; Schwamm LH
Am J Cardiol; 2009 Jan; 103(2):227-31. PubMed ID: 19121441
[TBL] [Abstract][Full Text] [Related]
2. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting.
McCormick D; Gurwitz JH; Goldberg RJ; Becker R; Tate JP; Elwell A; Radford MJ
Arch Intern Med; 2001 Nov; 161(20):2458-63. PubMed ID: 11700158
[TBL] [Abstract][Full Text] [Related]
4. Improvement in use of anticoagulation therapy in patients with ischemic stroke: results from Get With The Guidelines-Stroke.
Lewis WR; Fonarow GC; Grau-Sepulveda MV; Smith EE; Bhatt DL; Hernandez AF; Olson D; Peterson ED; Schwamm LH
Am Heart J; 2011 Oct; 162(4):692-699.e2. PubMed ID: 21982662
[TBL] [Abstract][Full Text] [Related]
5. An emergency department intervention to increase warfarin use for atrial fibrillation.
Skolarus LE; Morgenstern LB; Scott PA; Lisabeth LD; Murphy JB; Migda EM; Brown DL
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):199-203. PubMed ID: 23265781
[TBL] [Abstract][Full Text] [Related]
6. Prevention of stroke in patients with atrial fibrillation.
Olsson SB; Halperin JL
Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
[TBL] [Abstract][Full Text] [Related]
7. Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany - results from the German AFNET registry.
Haeusler KG; Gerth A; Limbourg T; Tebbe U; Oeff M; Wegscheider K; Treszl A; Ravens U; Meinertz T; Kirchhof P; Breithardt G; Steinbeck G; Nabauer M;
BMC Neurol; 2015 Aug; 15():129. PubMed ID: 26242880
[TBL] [Abstract][Full Text] [Related]
8. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.
Yang X; Li Z; Zhao X; Wang C; Liu L; Wang C; Pan Y; Li H; Wang D; Hart RG; Wang Y; Wang Y;
Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643
[TBL] [Abstract][Full Text] [Related]
9. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).
Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M
Eur Heart J; 2006 Aug; 27(16):1954-64. PubMed ID: 16847008
[TBL] [Abstract][Full Text] [Related]
10. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
12. Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a Veterans Affairs medical center.
Bradley BC; Perdue KS; Tisdel KA; Gilligan DM
Am J Cardiol; 2000 Mar; 85(5):568-72. PubMed ID: 11078269
[TBL] [Abstract][Full Text] [Related]
13. Barriers to warfarin use for stroke prevention in patients with atrial fibrillation in Hong Kong.
Lee VW; Tam CS; Yan BP; Man Yu C; Yin Lam Y
Clin Cardiol; 2013 Mar; 36(3):166-71. PubMed ID: 23151816
[TBL] [Abstract][Full Text] [Related]
14. Is warfarin really underused in patients with atrial fibrillation?
Weisbord SD; Whittle J; Brooks RC
J Gen Intern Med; 2001 Nov; 16(11):743-9. PubMed ID: 11722687
[TBL] [Abstract][Full Text] [Related]
15. Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation.
Koga M; Yoshimura S; Hasegawa Y; Shibuya S; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Todo K; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Yagita Y; Kario K; Shiozawa M; Sato S; Yamagami H; Arihiro S; Toyoda K;
Stroke; 2016 Oct; 47(10):2582-8. PubMed ID: 27531346
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial.
Al-Khatib SM; Thomas L; Wallentin L; Lopes RD; Gersh B; Garcia D; Ezekowitz J; Alings M; Yang H; Alexander JH; Flaker G; Hanna M; Granger CB
Eur Heart J; 2013 Aug; 34(31):2464-71. PubMed ID: 23594592
[TBL] [Abstract][Full Text] [Related]
17. Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation.
Alli O; Doshi S; Kar S; Reddy V; Sievert H; Mullin C; Swarup V; Whisenant B; Holmes D
J Am Coll Cardiol; 2013 Apr; 61(17):1790-8. PubMed ID: 23500276
[TBL] [Abstract][Full Text] [Related]
18. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
19. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
